^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
AUR-107
i
Other names: AUR-107, AUR107
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Dr. Reddy’s
Drug class:
CBP inhibitor, EP300 inhibitor
Related drugs:
3ms
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov)
P1, N=50, Recruiting, Aurigene Discovery Technologies Limited | Not yet recruiting --> Recruiting
Enrollment open
|
MUC16 (Mucin 16, Cell Surface Associated)
|
AUR-107
12ms
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov)
P1, N=50, Not yet recruiting, Aurigene Discovery Technologies Limited
New P1 trial • Metastases
|
AUR-107
Share via
